File S1 - Preclinical Validation of Talaporfin Sodium-Mediated Photodynamic Therapy for Esophageal Squamous Cell Carcinoma

Supporting data. Data S1, The fluorescence intensity of talaporfin sodium in cultured ESCC cells. (A) TE-5, (B) TE-8, (C) TE-10, (D) TE-11, (E) TE-5R, (F) TE-11R, Comp-APC-A: Compensated-Allophycocyanin (APC)-Area. Data S2, Cytotoxic effect of t-PDT on ESCC cells. The number of viable cells after t-PDT was expressed as a percentage of unirradiated control cells. (A) TE-5, (B) TE-8, (C) TE-10, (D) TE-11, (E) TE-5R, (F) TE-11R. Data S3, Flow cytometric analysis with Annexin V/Propidium iodide double-staining. Annexin V and Propidium iodide (PI) is detected by FITC and phycoerythrin (PE), respectively. Data S4, Xenograft tumor size. Each table represents the tumor volume (upper table) and the response rate (lower table). (XLSX)

补充数据。
数据S1：培养的食管鳞状细胞癌（Esophageal Squamous Cell Carcinoma, ESCC）细胞中他拉泊芬钠的荧光强度。(A) TE-5、(B) TE-8、(C) TE-10、(D) TE-11、(E) TE-5R、(F) TE-11R；Comp-APC-A：补偿型别藻蓝蛋白（Allophycocyanin, APC）区域。
数据S2：他拉泊芬光动力疗法（talaporfin Photodynamic Therapy, t-PDT）对食管鳞状细胞癌（ESCC）细胞的细胞毒性效应。经t-PDT处理后的活细胞数以未照射对照组细胞的百分比形式呈现。(A) TE-5、(B) TE-8、(C) TE-10、(D) TE-11、(E) TE-5R、(F) TE-11R。
数据S3：膜联蛋白V/碘化丙啶（Propidium iodide, PI）双染色流式细胞术分析。膜联蛋白V与碘化丙啶（PI）分别通过异硫氰酸荧光素（Fluorescein Isothiocyanate, FITC）与藻红蛋白（Phycoerythrin, PE）进行检测。
数据S4：异种移植瘤体积。每张表格分别包含肿瘤体积（上表）与肿瘤应答率（下表）。(XLSX)